The expansion of the marine hatchery trial facilities into a larger state-of-the-art facility follows the continued success of BioMar’s LARVIVA hatchery feeds across the main hatchery markets, together with the two capacity expansions at the production facility in France to cover the market demand.
“We believe that this investment will unlock potential for growth in new markets and new species,” said Henrik Aarestrup, BioMar's shrimp and hatchery VP LATAM, in a press release. “The expansion of the ATC Hirtshals facility aligns with BioMar’s strategic plan for the hatchery segment, which is a key pillar for the development of marine fish and shrimp feeds.”
The hatchery trial facilities will serve as a hub for research and development activities, with the addition of six multinational R&D staff to the team of experts in marine hatchery operations. It will include units dedicated to larval rearing as well as live feed production, allowing for extensive research and testing of hatchery feeds for several marine species.
Simon Wadsworth, global R&D director at BioMar added: “We are commissioning advanced larval research facilities to ensure the continued high performance of LARVIVA, as well as developing further products for this highly specialised global market. The core research team has also been strengthened by leading larval rearing expertise from the Mediterranean region. The new facility will significantly strengthen our research capacity in this dynamic segment.”
The inauguration of the expanded ATC Hirtshals facility is expected to take place in September.